Literature DB >> 21358961

Management of unexplained symptoms in survivors of cancer.

Michael Feuerstein1, Gina L Bruns, Courtney Pollman, Briana L Todd.   

Abstract

Quality health care for survivors of cancer must evaluate and manage symptoms that are reported at the surveillance visit but are not linked to a cancer recurrence or a new cancer. At present, this does not always occur. This article analyzes quality of health care for survivors of cancer, taking empirical evidence and clinical expertise into consideration. Although emotional distress on the part of the survivor of cancer may exacerbate or even explain the presence of experienced symptoms, there are other potential explanations as well. When survivors present with persistent symptoms (even if unexplained) after cancer diagnosis and treatment, the symptoms can impact the survivor's function and well-being. Oncologists and other providers need to assess and directly target these symptoms for appropriate triage to those who can best help these survivors reduce the symptoms and their impact.

Entities:  

Year:  2010        PMID: 21358961      PMCID: PMC2988665          DOI: 10.1200/JOP.2010.000088

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN: 1554-7477            Impact factor:   3.840


  31 in total

Review 1.  Assessment and management of medically unexplained symptoms.

Authors:  Simon Hatcher; Bruce Arroll
Journal:  BMJ       Date:  2008-05-17

Review 2.  Chronic pain and posttraumatic stress disorder: mutual maintenance?

Authors:  T J Sharp; A G Harvey
Journal:  Clin Psychol Rev       Date:  2001-08

Review 3.  Cancer survivorship research: challenge and opportunity.

Authors:  Noreen M Aziz
Journal:  J Nutr       Date:  2002-11       Impact factor: 4.798

4.  Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory.

Authors:  C S Cleeland; T R Mendoza; X S Wang; C Chou; M T Harle; M Morrissey; M C Engstrom
Journal:  Cancer       Date:  2000-10-01       Impact factor: 6.860

Review 5.  Integrative nonpharmacologic behavioral interventions for the management of cancer-related fatigue.

Authors:  Karen M Mustian; Gary R Morrow; Jennifer K Carroll; Colmar D Figueroa-Moseley; Pascal Jean-Pierre; Geoffrey C Williams
Journal:  Oncologist       Date:  2007

6.  Surviving cancer: a comparison of 5-year disease-free breast cancer survivors with healthy women.

Authors:  Vicki S Helgeson; Patricia L Tomich
Journal:  Psychooncology       Date:  2005-04       Impact factor: 3.894

7.  Medically unexplained physical symptoms, anxiety, and depression: a meta-analytic review.

Authors:  Peter Henningsen; Thomas Zimmermann; Heribert Sattel
Journal:  Psychosom Med       Date:  2003 Jul-Aug       Impact factor: 4.312

8.  Breast cancer survivors at work.

Authors:  Jennifer A Hansen; Michael Feuerstein; Lisseth C Calvio; Cara H Olsen
Journal:  J Occup Environ Med       Date:  2008-07       Impact factor: 2.162

9.  Relationship of catastrophizing to fatigue among women receiving treatment for breast cancer.

Authors:  Paul B Jacobsen; Michael A Andrykowski; Christina L Thors
Journal:  J Consult Clin Psychol       Date:  2004-04

10.  Symptom burden in cancer survivorship.

Authors:  V Shannon Burkett; Charles S Cleeland
Journal:  J Cancer Surviv       Date:  2007-06       Impact factor: 4.062

View more
  3 in total

1.  Adaptation of the illness trajectory framework to describe the work of transitional cancer survivorship.

Authors:  Rachel Klimmek; Jennifer Wenzel
Journal:  Oncol Nurs Forum       Date:  2012-11       Impact factor: 2.172

2.  The importance of symptom surveillance during follow-up care of leukemia, bladder, and colorectal cancer survivors.

Authors:  Erin E Kent; Sandra A Mitchell; Ingrid Oakley-Girvan; Neeraj K Arora
Journal:  Support Care Cancer       Date:  2013-09-10       Impact factor: 3.603

3.  The validity and utility of the M. D. Anderson Symptom Inventory in patients with breast cancer: evidence from the symptom outcomes and practice patterns data from the eastern cooperative oncology group.

Authors:  Tito R Mendoza; Fengmin Zhao; Charles S Cleeland; Lynne I Wagner; Linda J Patrick-Miller; Michael J Fisch
Journal:  Clin Breast Cancer       Date:  2013-06-28       Impact factor: 3.225

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.